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Book Reviews
Editorial Announcement
The review of the book 'Urological Oncology' edited
by Waxman and Williams which appears below
replaces the incorrect review published in the British
Journal of Cancer in January 1993. The review pub-
lished in January did, in fact, relate to a different book
'Urological Oncology - Dilemmas and Developments'
edited by A.R. Alderson et al. and published by John
Wiley & Son.
Urological Oncology
Edited by J. Waxman & G. Williams, Sevenoaks, Kent:
Edward Arnold, 1992 252 pp. £49.50.
With the rapid advances in many areas of urology, the
publication of a state-of-the-art survey of urological onco-
logy is long overdue. Great progress has been made in a
number of areas of urological oncology, especially in the
treatment of tumours of the prostate, bladder and testis. The
editors are to be congratulated for bringing together authori-
tative contributions from acknowledged experts in this
difficult field of urology.
The information presented reinforces the widely-held belief
that cancer treatment in urology should be performed in
specialist centres and that there are many questions currently
left unanswered. It is refreshing to see both sides of the
argument concerning radical treatment of early prostate
cancer although claims, in the introduction, that patients can
be cured of advanced bladder cancer by combination chemo-
therapy are not borne out by the text. One or two things
niggle, however; the chapter on surgery for Stage I testicular
cancer is not, in truth, about Stage I cancer but about
surgical lymphadenectomy since a significant proportion of
patients are upstaged (to Stage II) following surgery and
there are still no firm conclusion to be drawn about the
timing of inguinal lymph node dissection in penile carcinoma.
Much emphasis has been placed by the authors on patient
selection for treatment, on optimal timing for treatment and
on minimisation of toxicity with guidelines on patient selec-
tion; all too often the need to obtain information from
clinical trials overshadows the individual needs of the patient.
However, prospects for the future are well-covered with sec-
tions on molecular biology, oncogenes and identification of
peptide antagonists of tumour growth factors; and the rela-
tively new concept of chemoembolisation for advanced
tumours of the kidney will stimulate a great deal of interest
in oncological circles.
The book is sparsely illustrated but this does not detract
from its overall value. The text is widely referenced to a high
standard with most of the current literature in oncological
advances cited and all urologists will find further stimulation
from following up the listings. This volume should certainly
be on the shelves of all urologists, regardless of whether they
practice as cancer specialists and the informative nature of
the text, with opposing arguments carefully laid out, should
encourage more junior surgeons to delve within for a balanc-
ed assessment of current thinking in urological cancer
therapy. With a surge in oncologists' interest directed
towards oncogenes and genetic manipulation for cancer treat-
ment, we can all look forward to updates of this volume
which has set the baseline for the exciting developments in
urological cancer treatment which are surely just over the
horizon.
N. Bullock
Cancer in Children. Clinical Management. 3rd Edition
Edited by P.A. Vofite, A. Barrett & J. Lemerle, Heidelberg:
Springer-Verlag, 1992, 365 pp. 148,00 DM.
The second edition of this book appeared in 1986 and was
one of the only textbooks on paediatric oncology which
described European experience and treatment strategies. At
that time, as to some extent is still the case, the majority of
textbooks had a major American bias. The UICC book
therefore provided an invaluable and up to date reference
source for the increasing number of paediatricians who at
that time were entering this subspeciality. The new 'Com-
pletely Revised Edition' appears 6 years later, but still com-
pressed into the same 365 pages. Over the past decade there
have been significant advances, not only in the outcome in a
number of childhood cancers, but also in our understanding
of the biology of these rare tumours. To what extent does
this new edition reflect these advances?
The overall layout of the book follows convention, with
initial general chapters covering areas such as aetiology,
cytogenetics and infections. The succinct chapter on radiation
therapy is of particular use to a readership which may have
little experience in this field. More detail on the theory of
methods of delivering radiotherapy with regard to rate and
fractionation would have been of interest.
In an expanded chapter on cancer chemotherapy, mechan-
isms and toxicity are discussed with a brief consideration of
drug pharmacokinetics. It is a little surprising to not see any
mention of formula based dose individualisation for carbo-
platin, which is an important advance over empirical dose
prescription. The slightly misleading terminology when de-
scribing drug schedules should be noted. The term 'for 3
weeks' appears repeatedly, where it should read 'every 3
weeks'.
A short chapter considers the place of surgery, although as
in the case of the section on application of radiotherapy, to a
large extent these issues are considered in the disease related
sections.
The chapter on the late sequelae reviews the increasing
body of data regarding growth, neurological and other organ
toxicity. It would have been useful to have had the authors'
firm views on the indications for growth hormone in
leukaemia patients and the frequency and nature of follow-
up in children who have had anthracycline or bleomycin - all
practical issues.
The section on ALL overviews the German BFM experi-
ence and current protocols. One of the particular values of
the UICC book is to provide data from the BFM group,
which is often difficult to find in print elsewhere.
As in the previous edition, the arguments for and against
elective bone marrow transplantation are reviewed in a
balanced manner and useful tables of relative indications are
given for a variety of clinical scenarios.
Separate chapters cover B cell and T cell NHL. With the
increasing unification of immunohistological classifications
for childhood NHL it is now probably inappropriate to
separate these in this manner. In neither chapter is a com-
pletely satisfactory histological classification system de-
scribed. There is an urgent need for paediatricians to produce
a consensus system, probably a modified Kiel classification,
in order to avoid the recurring problem of people talking at
crossed purposes.
In the section on Hodgkin's disease, which provides an
excellent overview of current treatment strategies, it would
again have been of interest to have the authors' views on the
optimum treatment stage by stage, in terms of balance
between chemotherapy and radiotherapy. Some of the newer
non-sterilising chemotherapy regimens are also omitted from
this discussion.
Although rare, the malignant germ cell tumours of child-